About
Thermal ablation therapy, Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyUncategorized Medical DeviceBoston & New England
Team (15)
Ajay Royan
Chair of Fractyl HealthCo-Founder and Managing General Partner, Mithril Capital
Fractyl Health
board_chairfounder
Christopher C. Thompson, M.D., MSc
Professor of Medicine at Harvard Medical School and Director of Endoscopy at Brigham and Women’s Hospital
Fractyl Health
team_member
Clive Meanwell
Executive Chairman and Founder of Population Health Partners
Fractyl Health
board_chairfounder
Harith Rajagopalan, M.D., Ph.D.
Co-Founder and Chief Executive Officer, Fractyl Health
Fractyl Health
executivefounder
Ian Sheffield
Managing Partner, North Country Holdings, LLC
Fractyl Health
team_member
Jay Caplan
Co-Founder, President and Chief Product Officer
Fractyl Health
executivefounder
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
7
As Collaborator
4
Total Enrollment
1,562
By Phase
NA: 10
By Status
COMPLETED: 5SUSPENDED: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06825637Collaborator
The Use of SmartPhone App (Kandoo) to Enhance Efficacy of Brief Behavioral Activation in Reducing Mood Disorder Symptoms
NANot yet recruiting
200 participants
Started: Mar 31, 2025 · Completed: Aug 31, 2026
NCT06484114Lead Sponsor
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
NAActive, not recruiting
315 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2027
NCT06092476Collaborator
Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients
NARecruiting
18 participants
Started: Aug 9, 2024 · Completed: Dec 1, 2026
NCT06256497Lead Sponsor
A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient With Type 2 Diabetes
N/ASuspended
100 participants
Started: Jun 27, 2023 · Completed: Dec 1, 2028
NCT05048966Collaborator
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
NAUnknown
360 participants
Started: Dec 8, 2022 · Completed: Sep 30, 2025
Locations (1)
Headquarters
Burlington, MA, United States
Map
Loading map...